Trinity Biotech plc
TRIB
$0.708
$0.067910.61%
NASDAQ
06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 09/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.32M | 3.69M | 6.26M | 14.23M | 7.25M |
Total Receivables | 17.71M | 13.01M | 16.69M | 16.11M | 19.03M |
Inventory | 22.96M | 19.93M | 20.88M | 22.58M | 23.55M |
Prepaid Expenses | -- | 2.04M | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 373.00K | -- | -- | -- |
Total Current Assets | 45.98M | 39.04M | 43.83M | 52.92M | 49.83M |
|
|||||
Total Current Assets | 45.98M | 39.04M | 43.83M | 52.92M | 49.83M |
Net Property, Plant & Equipment | 3.91M | 1.89M | 1.80M | 1.87M | 6.08M |
Long-term Investments | -- | 0.00 | -- | -- | -- |
Goodwill | -- | 0.00 | -- | -- | -- |
Total Other Intangibles | 41.79M | 1.17M | 16.16M | 15.76M | 37.14M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.68M | 17.34M | 1.80M | 1.45M | 4.84M |
Total Assets | 94.36M | 59.44M | 63.60M | 71.99M | 97.90M |
|
|||||
Total Accounts Payable | 23.07M | 3.89M | 10.63M | 12.57M | 14.45M |
Total Accrued Expenses | -- | 8.07M | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.36M | 1.90M | 1.81M | 1.85M | 210.00K |
Total Finance Division Other Current Liabilities | 333.00K | 1.18M | 302.00K | 337.00K | 71.00K |
Total Other Current Liabilities | 333.00K | 1.18M | 302.00K | 337.00K | 71.00K |
Total Current Liabilities | 25.77M | 15.04M | 12.74M | 14.76M | 14.73M |
|
|||||
Total Current Liabilities | 25.77M | 15.04M | 12.74M | 14.76M | 14.73M |
Long-Term Debt | 80.77M | 54.65M | 54.28M | 53.93M | 57.70M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 10.20M | 10.87M | 10.92M | 11.55M | 11.82M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 7.01M | 2.83M | 3.14M | 3.14M | 7.02M |
Total Liabilities | 123.76M | 83.38M | 81.08M | 83.37M | 91.26M |
|
|||||
Common Stock & APIC | 52.28M | 48.59M | 48.59M | 48.59M | 55.26M |
Retained Earnings | -57.79M | -48.64M | -42.14M | -36.15M | -17.93M |
Treasury Stock & Other | -23.89M | -23.90M | -23.94M | -23.82M | -30.70M |
Total Common Equity | -29.40M | -23.95M | -17.49M | -11.38M | 6.63M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -29.40M | -23.95M | -17.49M | -11.38M | 6.63M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -29.40M | -23.95M | -17.49M | -11.38M | 6.63M |
|